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Background: Extraneuronal levels of the neurotransmitter glutamate in brain rise during aging. This is thought to
lead to synaptic dysfunction and neuronal injury or death. To study the effects of glutamate hyperactivity in brain,
we created transgenic (Tg) mice in which the gene for glutamate dehydrogenase (Glud1) is over-expressed in
neurons and in which such overexpression leads to excess synaptic release of glutamate. In this study, we analyzed
whole genome expression in the hippocampus, a region important for learning and memory, of 10 day to 20 month
old Glud1 and wild type (wt) mice.
Results: During development, maturation and aging, both Tg and wt exhibited decreases in the expression of
genes related to neurogenesis, neuronal migration, growth, and process elongation, and increases in genes related
to neuro-inflammation, voltage-gated channel activity, and regulation of synaptic transmission. Categories of genes
that were differentially expressed in Tg vs. wt during development were: synaptic function, cytoskeleton, protein
ubiquitination, and mitochondria; and, those differentially expressed during aging were: synaptic function, vesicle
transport, calcium signaling, protein kinase activity, cytoskeleton, neuron projection, mitochondria, and protein
ubiquitination. Overall, the effects of Glud1 overexpression on the hippocampus transcriptome were greater in the
mature and aged than the young.
Conclusions: Glutamate hyperactivity caused gene expression changes in the hippocampus at all ages. Some of
these changes may result in premature brain aging. The identification of these genomic expression differences is
important in understanding the effects of glutamate dysregulation on neuronal function during aging or in
neurodegenerative diseases.
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Glutamate (Glu) is the major excitatory neurotransmitter in
the mammalian central nervous system (CNS). Glutamate
activation of post-synaptic receptors leads to rapid exci-
tation of neurons as well as long-lasting effects on
neuronal structure and function [1,2]. Among the long-* Correspondence: xwang@ku.edu
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reproduction in any medium, provided the orlasting effects of Glu on neurons are changes in synaptic
excitability [1,3,4], altered metabolic states and generation
of reactive oxygen species in neurons [2,5-7], increases
in intracellular calcium (Ca2+) concentrations, and upon
exposure to high Glu levels, neuronal injury or cell
death [8-11].
There are two other important neurobiological pro-
cesses that are influenced by Glu release and the activa-
tion of neuronal Glu receptors. These are the cellular
events occurring during CNS development and the neur-
onal changes related to the aging process. Glutamatetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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neurogenesis and the survival of neurons during early de-
velopment [5,12,13], as well as to neuronal migration [14]
and synaptic formation in the developing brain [15,16].
With regard to the aging process, neuronal, dendritic, and
synaptic losses in hippocampus, subiculum, dentate gyrus,
and pre-frontal cortex are subtle [17-19] and may be
partially the result of a gradual rise in extracellular Glu
in the aging brain [20-22]. An age-associated increase
in the sensitivity of certain neurons to the cytotoxic
effects of Glu [23] and a significant decrease in the
dendrite levels of the microtubule-associated protein 2
(MAP2), a marker protein of dendrite structure, have
been described [24,25]. Given the strong relationship
between Glu hyperactivity and decreases in MAP2 label-
ing in dendrites of sensitive neurons [26-28], the MAP2
decreases in aging brain may represent a sign of increased
Glu activation of receptors in susceptible neurons.
The study of neuronal responses to persistently high
levels of Glu activity at synapses during development
and aging requires the use of transgenic or null mutant
animals that either exhibit diminished Glu re-uptake
into neurons and glial cells [29-31] or have increased
synaptic Glu release [32]. Null mutant mice for the high
affinity glial Glu transporter genes Slc1a2 (Solute carrier
family 1 member 2) and Slc1a3 exhibit high levels of
extracellular Glu and suffer extensive brain damage and
embryonic lethality [29-31]. Null mutants for the gene
Tsc1 (Tuberous sclerosis complex-1), a gene that is
closely associated with the expression and function of
Glu transporters in the CNS, also have high extracellular
levels of Glu and suffer from extensive neuronal damage,
intractable seizures, and marked reduction in their life-
span [33]. Therefore, none of these mice would be suit-
able for studies of both developmental and aging effects
of excess Glu synaptic activity on brain cells. On the
other hand, transgenic (Tg) mice over-expressing the
gene for Glu dehydrogenase 1 (Glud1), a mitochondrial
matrix enzyme, only in CNS neurons have lifelong
excess synaptic release of Glu, selective neuronal de-
generation in vulnerable brain regions, such as the
hippocampus, and a close to normal lifespan [32,34].
The Glud1 Tg mouse was selected to further characterize
the effects of moderate excess Glu activity on gene ex-
pression patterns in the developing, adult, middle-aged,
and aging mouse brain. Whole genome transcription
patterns represent an unbiased assessment of changes
in genes involved in brain metabolism, neuronal excit-
ability, neuronal structure, and the response to meta-
bolic, oxidative and other types of stresses related to
Glu hyperactivity throughout development, adulthood
and aging. In the present study, we determined the
gene expression patterns in Tg and wt mice from
10 days to 20 months of age.Results and discussion
We performed genome wide transcriptomic analyses of
the hippocampus at 5 ages, from early development at
10 days postnatal, to young adult (4.5 months), adult
(9 months), middle aged (14.5 months), and old age
(20 months). We included a group of very young mice,
the 10 day old mice, so that we may assess the effects of
the over-expressed Glud1 gene on the overall patterns of
gene expression during the development of Tg and wt
mice. The brain region of interest was the hippocampus.
Transcriptomic similarities between Glud1 Tg and wt
mouse hippocampus from 10 days to 20 months of age
Of the 45,037 gene probesets on the Affymetrix
GeneChip arrays (Mouse Genome 430 2.0) that we
employed in this study, we identified 895 genes whose
expression was changing during development, maturation,
and aging, and whose patterns of age-related changes were
similar in both Tg and wt hippocampus. In this group of
895 genes, the majority were genes whose expression
levels decreased with advancing age. The expression of
only a relatively small fraction of the 895 genes increased
gradually with age.
As shown in Figure 1, the genes that exhibited similar
age-related changes in wt and Tg mice can be separated
into two clusters. The two clusters were characterized as
consisting of: 1) genes with high levels of expression in
the 10-day old hippocampus but whose expression de-
creased with advancing age; and 2) of genes with low
levels of expression in the 10-day old hippocampus but
whose expression increased with advancing age. To deter-
mine which functions are associated with the genes whose
expression diverged, the Gene Ontology (GO) categories
significantly enriched with such genes were identified.
For the genes whose expression in hippocampus de-
creased with advancing age, the biological functions in
the GO categories were: 1) Cytoskeleton (including actin
filament and microtubule); 2) Neurogenesis; 3) Neuron
projection/growth cone/axon guidance/axonogenesis; 4)
Small-GTPase-mediated signal transduction; 5) Cholesterol
biosynthesis; 6) Cell migration; 7) Cell cycle and cell
division; and 8) Protein disulfide oxidoreductase activity
and cell redox homeostasis. For the genes whose expres-
sion increased with advancing age, the significantly
enriched GO categories included the following: 1) Axon
and neuron projection; 2) Actin binding; 3) Small GTPase
regulator activity; 4) Voltage-gated channel activity
(mostly potassium); 5) Protein tyrosine kinase activity;
and 6) Regulation of synaptic transmission. It was noted
that two function categories, Cytoskeleton structure and
function and Axon and neuron projection, contained
genes that exhibited an age-associated up-regulation as
well as genes whose expression was down-regulated with
age. In addition to the biological functions mentioned
Figure 1 Hierarchical clusters of genes that were expressed in
Glud1 Tg and wt hippocampus with nearly identical patterns of
change during development and aging. Upper panel (demarcated
by red dashed line) includes the genes whose expression decreased
with age, while the lower panel shows genes whose expression
increased with age.
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being enriched with genes whose expression increased
with advancing age, the Chemokine signaling pathway.
The overall patterns of gene changes with age in both
wt and Tg mouse hippocampus could be viewed as being
characterized by a decline in aspects of neurogenesis,
neuronal migration, cytoskeleton function, cholesterol
biosynthesis, and cell redox regulation. While on the
other hand, neuroinflammation, protein tyrosine kinase
signaling, and voltage-gated potassium channel activity
were functions that increased during the transition from
newborn to adult and to old age. Increases with advan-
cing age in the expression of genes related to neuro-
inflammation are consistent with previous observations
of increases in the process of inflammatory response dur-
ing brain aging and in neurodegenerative diseases [35].
Transcriptomic differences between Glud1 Tg and wt
mouse hippocampi across the ages from 10 days to
20 months
The next issue that we explored was whether there were
differences in age-associated gene expression in the
hippocampus of wt vs. Tg mice. We identified 407 genes
that were differentially expressed in Tg vs. wt mouse
hippocampus. We noted that the Glud1 gene was not
among the differentially expressed genes. The reason for
that is related to the fact that the two sets of probes for
Glud1 on the GeneChip are designed to hybridize with
the 3’-UTR region of the gene transcript, a region that
was not present in the transgene construct that we had
inserted into the mouse genome of the Glud1 Tg mice.
Regardless of the lack of detection of excess Glud1 ex-
pression using the microarray chips, we have docu-
mented in our previous studies the insertion of the
Glud1 open reading frame in the genomic DNA of the
transgenic mice, as well as the over-expression of the
GLUD1 protein and increased glutamate dehydrogenase
activity in neurons [32], thus confirming the presence
and expression of the Glud1 transgene.
The major functions of the differentially expressed genes
are summarized in Table 1. Among these functions,
Mitochondrial envelop and Carboxylic acid transport
contain genes in the nuclear genome that code for pro-
teins related to mitochondrial metabolism and function.
These genes included: Crls1, coding for an enzyme that
catalyzes the biosynthesis of di-phosphatidyl glycerol
Table 1 Bio-functions (gene ontology terms) of differentially expressed genes in Glud1 Tg vs. wt hippocampus
across 5 ages
Term P value Key genes
Ras protein signal transduction 0.0016 Bcl6, Brap, Eps8l1, Hrasls, Nras, Ptplad1, Sdcbp
Metal ion transport (mostly for calcium and potassium) 0.0017 Atp1a2, Atp1b1, Atp2c1, Cacna1h, Cacnb4, Camk2g, Itpr2, Kcnab2,
Kcnip2, Kcnip3, Kcnk1,,Kcnq2, Kcnt1, Sfxn1, Slc25a28, Slc38a9, Trpc4
Synaptic transmission 0.013 Atp1a2, Cacnb4, Capza2, Cplx3, Grid2, Grm4, Lin7c, Stx1b
Carboxylic acid transport 0.017 Cacnb4, Serinc1, Slc13a3, Slc1a1, Slc1a7, Slc38a9, Trpc4,
Actin cytoskeleton organization 0.027 Acta1, Arhgef2, Atp2c1, Bcl6, Capza2, Dbn1, Neurl2, Nras, Sorbs1
Stress-activated protein kinase signaling pathway
(mostly MAPK and JNK cascades)
0.034 Brap, Cdc42se1, Errfi1, Fgf12, Fgf2, Gm8188, Map3k7, Myd88, Ptplad1
Mitochondrial envelop 0.05 Cds1, Cds2, Cox15, Cox4i2, Cox5a, Crls1, Cyb5b, Golph3, Nlrx1, Pi4kb,
Ppp1cc, Sfxn1, Slc25a28, Tomm20
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for enzymes that catalyze the conversion of phospha-
tidic acid to CDP-diacylglycerol, a precursor to the
synthesis of phosphatidyglycerol and cardiolipin; and
Cox4i2, Cox15, and Cox5A, genes coding structural and
regulatory components of the multimeric complex that
forms the mitochondrial enzyme cytochrome c oxidase
(Table 1). Cytochrome c oxidase is a key enzyme in the
electron transport system of mitochondria and one that
has been reported to be decreased in terms of expres-
sion levels and activity during aging and in Alzheimer’s
disease [36,37]. The differential expression of these
mitochondria-related genes during development, matur-
ation, and aging were suggestive of distinctive patterns of
activity between wt and Tg mouse hippocampus cells in
two key mitochondrial metabolic pathways, lipid biosyn-
thesis and oxidative phosphorylation.
In addition to the genes that code for mitochondrial
proteins, another group of important genes shown in
Table 1 are those of Metal ion transport, in particular,
those for potassium channels. Differential expression of
these genes would lead to differential regulation of
neuronal excitability, sensitivity to Glu-induced neuronal
damage, and neurocognitive function. Two of these
genes were Kcnq2 (also known as the M channel) and
Kcnt1, a sodium and calcium-regulated potassium chan-
nel. Mutations in these two genes are associated with
early onset epileptic seizures [38,39]. A third potassium
channel gene was Kcnab2, a gene that codes for the beta
subunit of voltage-gated potassium channels and whose
over-expression protects neurons from Glu-induced cell
damage [40] while its under-expression impedes associa-
tive memory formation [41].
Of all differentially expressed genes, we identified a
subgroup of eight genes which exhibited the most sig-
nificant differences. These eight genes were: Akt3, Cebpg,
Klhdc8a, Pex11b, Prrt4, Sfxn1, Tomm20, and Ubr7. Akt3,
a serine/threonine protein kinase (protein kinase B), isan important component of many signal transduction
pathways. Akt3 is involved in the regulation of cell pro-
liferation, tumorigenesis, differentiation, organismal de-
velopment, metabolism, synaptic transmission, and cell
junction formation [42]. Cebpg (CCAAT/enhancer bind-
ing protein gamma), a transcription factor, is associated
with stress pathways including antioxidant, DNA repair,
and immune responses [43,44]. Klhdc8a, one of the
Kelch domain-containing proteins that are connected to
the cytoskeleton, is related to neurite outgrowth and to
the development of drug-resistant forms of gliomas
[45,46]. Pex11b (peroxin 11b), a peroxisomal biogenesis
factor, interacts with proteins involved in mitochondrial
fission, is involved in lipid metabolism, myelin formation
and axonal growth, and mutations in this and related
Pex genes can lead to the inherited neurological and be-
havioral syndrome known as the Zellweger syndrome
[47,48]. Prrt4 (proline-rich transmembrane protein 4), a
gene related to Prrt2, may be associated with abnormal
neurological conditions as mutations in Prrt2 lead to
paroxysmal neurological states characterized by seizures
and dyskinesias [49]. Sfxn1 (sideroflexin 1) is a mito-
chondrial inner membrane tricarboxylate and iron car-
rier [50]. Tomm20 (translocase of outer mitochondrial
membrane 20 homolog), a component of a receptor-
translocase complex in the outer mitochondrial mem-
brane, is involved in recognition and subsequent trans-
port into mitochondria of precursor proteins synthesized
in the cytoplasm [51-53]. The differential expression
across age of the two mitochondrial genes Sfxn1 and
Tomm20 in Glud1 vs. wt mouse hippocampi might be
further evidence of functional differences between wt
and Tg mouse brain mitochondria. Finally, the differen-
tial expression patterns of Ubr7 (ubiquitin protein lig-
ase E3), a member of the family of N-terminal ubiquitin
ligases that are involved in the regulation of cellular
and organismal processes such as apoptosis, neurogen-
esis, and learning and memory [54-56], might be an
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ation of select proteins in Tg vs. wt mice.
Age-related periods with the highest and lowest
differential gene expression between Tg and wt
mouse hippocampi
Among the 407 differentially expressed genes, the differ-
ences between the Tg and wt mouse hippocampi were
not always in one direction, i.e., either over-expression
or under-expression of the genes in one mouse genotype
vs. the other. An analysis of the total number of genes
whose expression in hippocampus differed in Tg vs. wt
mice across the five ages is shown in Figure 2. In the
hippocampus of 10 day-old mice, there were relatively
few differences in gene expression between Glud1 and
wt mice, and most of the genes that were differentially
expressed were at lower levels (down-regulation) in the
Tg compared with the wt hippocampus. By 4.5 months
of age, the number of genes whose levels of expression
were lower in Tg than wt hippocampus had quadrupled
in comparison with the 10 day old mice but, once again,
only few genes were expressed at higher levels (up-
regulation) in Tg than wt mice at that age (Figure 2).
This pattern reversed dramatically at 9 months of age,
with a high number of genes being up-regulated in Tg
compared with wt hippocampus. Finally, in the last two
age groups— i.e. the 14.5 and 20 month old mice, the
populations of differentially expressed genes were relatively
small, approximately at the same levels as those at
10 days of age (Figure 2).
The high number of genes that were differentially
transcribed in 4.5 and 9 month-old Tg vs. wt mouse
hippocampus might suggest that this period represented
a critical stage in the maturation of the mouse hippo-
campus and that the over-expression of Glud1 in neu-
rons may have had the greatest effect around this ageFigure 2 Total number of genes (probesets) in Glud1 Tg
hippocampi that were either significantly under (green)- or
over (red) -expressed when compared with wt hippocampi
at each age examined.period. The GO categories enriched with genes that
were differentially expressed in Tg vs. wt mice at 4.5 and
9 months of age, revealed several key neurobiological
functions that were down-regulated at 4.5 months but
up-regulated at 9 months in Tg vs. wt mouse hippocam-
pus (Table 2). These functions were summarized as
Neuronal growth and development (including neuron
projection and nervous system development), Axonal path-
finding (including axonal guidance, cytoskeleton, focal
and cell adhesion), and Synapse formation and signaling
(including synaptic vesicle and synaptic transmission).
The group of genes related to neuronal growth and
development consisted of the transcription factors Fos,
Pbx1, Zeb2, and Egr2. Fos, FBJ murine osteosarcoma
viral oncogene homolog, is the first immediate early
gene identified to have an increased level of expression
following neuronal stimulation in brain and it, together
with other regulatory factors and immediate early genes,
may be involved in dendrite growth and synaptic plasti-
city [57,58]. Pbx1, pre-B-cell leukemia homeobox 1, is a
homeodomain gene involved in early neuronal develop-
ment, axon pathway finding, and regulation of compul-
sive behaviors [59-61]. Zeb2, zinc finger E-box binding
homeobox 2, is a gene that is involved in early brain de-
velopment and the regulation of myelination of neurons;
mutations of this gene lead to microcephaly, agenesis of
corpus callosum, and mental retardation [62]. Egr2, early
growth response 2, is a gene involved in axonal growth
and myelination and mutations in this gene are associ-
ated with congenital neurological diseases characterized
by hypo-myelination and abnormal axonal growth and
function in the peripheral nervous system [63]. Other
differentially expressed genes related to neurite growth,
pathway finding, and synapse formation included the
gene Ndel1 coding for a cytoskeleton-organizing protein
that controls neuron migration and outgrowth [64], the
gene Nrca involved in neuronal cell adhesion, axonal
growth and directional migration [65], and the gene
Ntrk2 coding for the receptor of brain-derived neuro-
trophic factor (BDNF) and involved in dendritic spine
growth and synapse formation [66,67]. The lower levels
of expression of these genes in 4.5-month-old Tg as
compared with wt mouse hippocampus might be an in-
dication of delayed neuronal growth, axonal projection,
and synapse formation in the Tg mice.
At ages past 9 months, the differences in gene expres-
sion between the Glud1 and wt mouse hippocampi were
not as pronounced as at 4.5 and 9 months. Functional
analyses of the GO categories significantly enriched with
differentially expressed genes at these ages were indica-
tive of some important neurobiological functions that
differed between Tg and wt mouse hippocampi, such
as cell adhesion and extracellular region, ion transport,
voltage-gated channel, and synaptic activity (Table 2).
Table 2 Bio-functions of down- or up-regulated genes in Glud1 Tg compared with wt hippocampus at various ages
Age group Down-regulated Up-regulated
10 days post birth Ion binding and transport, transmembrane transport,
extracellular space, neuronal development, metabolism
and energy generation
4.5 months Neuron projection, axonal guidance, synaptic transmission,
ion binding, cytoskeleton, protein ubiquitination, intracellular
transport, cell adhesion, synaptic vesicle
9 months Signal transduction, nervous system development, cell
adhesion, synaptic transmission, ion homeostasis
Nervous system development, signal transduction, cytoskeleton,
focal adhesion, ion transport, synaptic transmission, protein folding
and degradation
14.5 months Extracellular region, cell adhesion, and ion transport
20 months Voltage-gated channel Synapse
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“developmental” and “aging” stages of life
The results of analyses of gene expression patterns out-
lined above were obtained by treating the data as if the
age-associated changes in expression in Tg and wt
hippocampi were part of a biological process that is
expressed in a continuum from 10 days post-natal to
20 months of old age. But, we know that the immediate
post-natal period up to 2-3 months of age is character-
ized by many changes in tissues, especially in the brain,
that would be considered as developmental events. Simi-
larly, the changes in cell and organ function with advan-
cing age from 14.5 to 20 months would be considered
part of organismal aging. For this reason, we decided to
re-analyze the data on gene expression as falling into
two phases in the life spectrum, a “developmental” and
an “aging” stage of life. The age of 9 months appeared to
represent an approximate midpoint between these two
stages. Therefore, the transcriptomic data were re-analyzed
by dividing them into a “developmental stage” that encom-
passed the period between 10 days and 9 months of age,
and an “aging stage” between 9 and 20 months.
In the developmental stage, our analysis identified 217
genes which exhibited both age-dependent changes and
significant expression differences between the Glud1 and
wt mice. Hierarchical clustering of these genes according
to changes in their expression from 10 days to 4.5 and
9 months of age is shown in Figure 3. The top group
shown in Figure 3 (group I) had high levels of expression
at 10 days of age and progressively lower levels at 4.5
and 9 months. The decrease in the expression of these
genes in the Tg hippocampus at 9 months was much
greater than that detected in wt mice. A GO analysis of
the genes in this group indicated that the biological
functions significantly enriched with these genes were
RNA recognition and binding, Calcium and other metal ion
binding, Protein kinase activity, Cytoskeleton, and Synapse.
The bottom group of genes shown in Figure 3 (group II),
had a pattern of increasing expression with advancing
age from 10 days to 9 months. These genes were alsodifferentially expressed in Tg vs. wt mouse hippocampus.
The expression levels of these genes at 9 months of
age were significantly higher in Tg compared with wt.
The GO categories enriched with these genes were:
Synaptic transmission, Neuron projection and cytoskeleton,
Endomembrane system (including nuclear envelop and
Golgi apparatus), Metal ion binding and channel activity,
Protein catabolic process, Cell adhesion, Plasma mem-
brane, Mitochondrion, and Regulation of apoptosis. The
expression changes for these genes suggested that during
the developmental stage, the hippocampus of the Glud1
mice differed from that of the wt in terms of important
neuronal structural and functional aspects, such as neur-
onal projection and neurite growth, protein degradation,
mitochondrial function, and metal ion binding and trans-
port. At the age of 9 months, the cells of the hippocampus
in the Tg mice had exceeded in the expression of most of
these genes the levels observed in the wt hippocampus.
A much greater number of probesets (1,257) than those
that were differentially expressed in the “developmental
stage” showed differential expression between Glud1 vs.
wt hippocampus during the “aging stage”, i.e., from 9 to
20 months of age (Figure 4). Only few of these genes had
a continuously increasing or decreasing pattern of expres-
sion from 9 to 20 months of age. Most genes fell into
one of two major groups: those whose expression in-
creased between 9 and 14.5 months and then decreased
at 20 months of age (marked as Group I in Figure 4),
and those whose expression decreased between 9 and
14.5 months and then increased again at 20 months
(Group III in the figure). Genes in Group I were further
separated into two subgroups based on their relative
expression levels in Tg vs. wt at the start of this aging
stage (marked as Subgroups I-1 and I-2 in Figure 4).
Genes in Subgroup I-1 were expressed at higher levels
in Tg than wt at 9 months of age, and the GO categor-
ies significantly associated with these genes included
Cytoskeleton, Golgi apparatus,Vesicle-mediated transport,
Calcium ion binding, and Protein transport. Since three of




Figure 3 Hierarchical clustering of genes that were differentially
expressed in the Tg vs. wt hippocampi during the “developmental
stage” (10 day, 4.5 and 9 month old). The clusters are further
subdivided into 3 gene expression patterns that were similar in Tg
and wt hippocampi even though there were differences in ov:
those decreasing in expression levels with advancing age and with
the expression in the Tg mice at 9 months being lower than the
wt (panel I); those with increasing expression with advancing age
and with the Tg expression levels being higher than the wt at
9 months (panel II); and those with a mixed pattern of age-related
change in expression (middle panel).
Wang et al. BMC Neuroscience 2014, 15:37 Page 7 of 17
http://www.biomedcentral.com/1471-2202/15/37processes, the expression pattern of these genes might
represent possible adaptations of cells in the Tg mouse
hippocampus that would lead to increased growth or
elongation of processes. Genes in Subgroup I-2 were
expressed at lower levels in Tg than wt at 9 months, and
the GO categories associated with these genes included
Regulation of transcription, Metal ion binding, and Protein
kinase activity, i.e., suggestive of changes in intracellular
signaling and regulation of protein synthesis in the Glud1
Tg mouse hippocampus.
Group III genes, i.e., those whose expression levels
decreased from 9 to 14.5 months and then partially
rebounded at 20 months, were similarly divided into two
subgroups. The genes in Subgroup III-2 (Figure 4) were
expressed at higher levels in Tg than wt at 9 months of
age, and the GO categories enriched with genes in this
subgroup were RNA binding, Protein kinase activity and
ATP binding, GTPase regulator activity, Microtubule
cytoskeleton, Actin skeleton, and Neuron projection. This
grouping showed, once again, that intracellular transport
and neurite projection processes, i.e., microtubule and
actin cytoskeleton, were at higher levels in Tg than wt
hippocampi at 9 months and appeared to increase again,
but moderately, at 20 months. Genes in the other sub-
group (III-1) were expressed at lower levels in Tg than
wt at 9 months, and the categorical GO functions
included Ribosome, Purine metabolism, Mitochondrion,
RNA binding, Proteolysis, Protein transport, and Calmodulin
binding. Thus, protein synthesis and metabolism, as well
as mitochondrial activity, appeared to be at lower levels
in Tg than wt hippocampus at 9 mos, and increased
only moderately at 20 months. Among the mitochondria-
related genes in this group was Crls1, the gene that codes
for cardiolipin synthase. Cardiolipin is almost exclusively
expressed in mitochondria and is present in the inner
mitochondrial membrane where it enhances the activity of
the electron transport system and ATP synthesis [68]. Car-
diolipin is susceptible to oxidation and loss of activity with
advancing age [69], therefore, the higher expression of
Crls1 in wt compared with that in Tg hippocampus may
afford greater retention of normal mitochondrial function
in wt than Tg mice during the aging process. The differen-







Figure 4 Hierarchical clustering of genes that were differentially
expressed in the Tg vs. wt hippocampi during the “aging stage”
(9, 14.5, and 20 month old). The clusters are further subdivided into
differing gene expression patterns across age of both Tg and wt mice.
A further subdivision of the clusters was made based on whether
the gene expression levels for the Tg hippocampi were higher at
9 months than those for the wt (see text for full description).
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different ages.
The gene categories described above were populated
with genes that were transcribed either at high or inter-
mediate levels at the start of the aging process. But,
there was another group of the genes shown in Figure 4
whose expression was at low levels at 9 months but in-
creased at 14.5 and 20 months in both Tg and wt mouse
hippocampi (Group II). This group of genes could also
be divided into two subgroups, one whose expression
was consistently higher in Tg than wt hippocampus at
9 months (Subgroup II-1), and the other lower in Tg
than wt (Subgroup II-2). For those genes in Subgroup
II-1, the biological functions represented were those of
Protein ubiquitination and degradation, Cytoskeleton
and cell projection, mRNA transport, Protein transport,
Chaperone activity, Endoplasmic reticulum, Mitochondrion,
and Regulation of apoptosis. Therefore, in addition to cyto-
skeleton, transport, and neurite growth that were charac-
teristic of genes enriched in the 9 month-old hippocampus
of Tg mice, cell and ER stress were also enriched in this
subgroup, specifically, protein ubiquitination, chaperone
activity, ER, protein degradation, and regulation of
apoptosis. Some of these biological functions will be
analyzed further in a subsequent section. The genes in
Subgroup II-2 were related to Synapse and synaptic
vesicle, RNA binding, Cell surface receptor linked signal
transduction, ER, Phosphatase activity, Regulation of
transcription, and Protein transport.
As summarized in Figure 5 on the effect of Glud1
transgene overexpression on mouse hippocampal aging,
neurite projection and growth, protein ubiquitination
and degradation, cytoskeleton and intracellular trans-
port, cellular and ER stress, and mitochondrial activity
were the major functional categories associated with
genes whose expression levels were up-regulated in the
Tg mice. Some genes related to mitochondrial activity
were also down-regulated in the aging stage, as was true
also with respect to genes related to synaptic function.
Combining the results from all ages, encompassing
both the developmental and aging stages, allowed us to
identify five categories of cell functions that were con-
sistently and significantly differentially regulated in Tg
vs. wt hippocampus. The first three were Cytoskeleton,
Intracellular transport, and Neurite projection and growth.
Aspects of differential expression of cytoskeleton and
Figure 5 Major functions of genes differentially regulated in Glud1 Tg vs. wt mice during the aging stage. Most functions, including
Neurite projection and growth, Protein ubiquitination and degradation, Cytoskeleton and intracellular transport, Cell and ER stress, and Mitochondrial
activity, were up-regulated in the Glud1 Tg mice.
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compared with those of wt mice were described previously
for a single age group, the 9 month old group [70] and will
be analyzed further in subsequent studies focused on the
function of axonal transport in the brain and hippocampus
(P. Lee, R. Pal, X. Wang, I-Y. Choi, and E. K. Michaelis,
unpublished observations). The other two key func-
tions were Protein ubiquitination and degradation,
and Mitochondrial structure and function, which are
analyzed next.
Differential gene expression of protein ubiquitination and
degradation in Tg vs. wt hippocampus
Increases in protein ubiquitination and degradation are a
characteristic of cellular responses to stress, occur in the
CNS during aging and in age-associated neurodegenera-
tive diseases, and are collectively referred to as altered
proteostasis [71,72]. In the present study, a number of
protein ubiquitination-related genes showed significant
differential expression between the Glud1 and wt mouse
hippocampus, with the Tg hippocampus exhibiting higher
levels of expression than the wt across several age groups
(Figure 6). Among the genes related to protein ubiquitina-
tion were two E2 ubiquitin conjugating enzymes, Ube2q1
(ubiquitin-conjugating enzyme E2q) and Hip2 (or Ube2k),
huntingtin interacting protein 2 (or ubiquitin conjugating
enzyme E2k). Ube2q1 is associated with the endocytic
pathway and the proteasomal degradation of proteins [73],
while Hip2 is involved in ubiquitination and aggregation
of polyglutamine-containing proteins such as the protein
huntingtin in Huntington’s disease [74]. In addition to the
two E2 ubiquitin-conjugating enzymes, three genes, Ubr7,
Ube3a and Itch, coding for E3 ubiquitin-protein ligaseswere also differentially expressed in Tg vs. wt mice, espe-
cially at the age of 9 months (Figure 6). In terms of the
role of these genes in CNS function, Ubr7 is one of fifty
genes whose mutations are linked to autosomal reces-
sive intellectual disabilities [75], while suppression of
the expression of Ube3a in the hippocampus and
cerebellum of children leads to the clinical syndrome
known as Angelman’s syndrome characterized by seizures
and mental and developmental disabilities [76]. Itch codes
for an E3 ligase that is associated with endothelin A and is
part of the endosomal degradation pathway in cells of the
nervous system [77].
As pointed out by others [78,79], the expression of
these genes may enhance axonal growth, dendritic spine
elongation and synapse formation during early develop-
ment or later in life, thus determining both the structure
and function of synapses through ubiquitination and
proteasomal degradation of key proteins. Included among
the proteins whose placement and cycling at synapses are
the Glu receptor proteins in glutamatergic synapses. Such
changes in the rates of placement and removal of macro-
molecules from synapses may alter synaptic transmission
and thus have a protective role in chronically stimulated
synapses, such as those that exist in the hippocampus of
the Glud1 Tg mice.
Several additional genes related to ubiquitination and
protein degradation, were over-expressed in the Tg as
compared with the wt hippocampus, including Cul4a
(ubiquitination complex E3 ligase component), a gene
which when over-expressed offers protection against
the damage induced by hypoxia and ischemia [80,81];
Fbxw1b (F-box and WD-containing 1b) which codes for
a component of a ubiquitination complex that includes
Figure 6 Patterns of age-related expression of four genes associated with protein ubiquitination. The genes are Ube2q1 (A), Ubr7 (B),
Ube3a (C), and Itch (D). Shown on the Y-axis are the logarithmic transformations (log2) of RMA-normalized expression values. The lines connecting the
points are: solid line, Tg; dotted line, wt.
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targeted proteins [82]; Rab40c, a member of an ubiquitin
E3 ligase complex and one that is highly expressed in oli-
godendrocytes and may be involved in myelin formation
or repair [83]; and, Usp7, 19, and 20 (ubiquitin specific
proteases 7, 19, and 20) and Psmd14 (proteasome 26 S
subunit non-ATPase 14), a proteasome component in-
volved in the degradation of proteins. Thus, the expres-
sion patterns of the genes for the ubiquitin conjugating
enzymes, the ubiquitin ligases, and the ubiquitin-specific
proteases enumerated above were suggestive of increased
endosomal transport, protein ubiquitination, and protea-
somal degradation of ubiquitinated proteins in Glud1 Tg
mouse hippocampus. Such differential expression might
lead to altered dynamics at synapses, altered proteostasis,
and possibly higher levels of ER stress in the Tg mice. Yet,
even such up-regulation of genes of the ubiquitin prote-
asome system (UPS) may not be sufficient in meeting the
increased demands of protein processing needed to main-
tain normal function in the Glud1 Tg mice. This mightexplain why neurons in the hippocampus of Glud1 Tg
mice, especially in the susceptible CA1 region of the
hippocampus, exhibit increasing amounts of ubiquitinated
protein aggregates after 14 to 16 months of age [32].
It should be noted, however, that not all genes that
code for ubiquitinating enzyme proteins were expressed
at higher levels in Tg mice throughout development or
aging. An example of a gene that was expressed at
higher levels in wt mice during early development as
well as in the aged mice is Birc6 (data not shown), a
gene that codes for an E2 ubiquitin-conjugating enzyme
containing a UBCc domain and a BIR (baculoviral inhib-
ition of apoptosis protein repeat) domain. Pro-apoptotic
proteins are ubiquitinated by BIRC6 and subsequently
degraded, and that leads to the suppression of apoptosis
of cells [84,85]. In the early developmental phase (10 days
to 4.5 months), Birc6 expression was significantly higher
in wt than Tg hippocampus. Such a deficiency in BIRC6
in Tg mice might produce a pro-apoptotic effect during
development and maturation of the hippocampus and
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the hippocampus of Glud1 mice [32].Differential expression of mitochondria-related genes in
Tg vs. wt hippocampus
As described above, genes related to mitochondrial
structure and function were also differentially expressed
in Glud1 Tg vs. wt mouse hippocampi. Mitochondria
play a crucial role in energy metabolism, oxidative stress,
apoptosis, calcium regulation, and aging-related neur-
onal injury. The up-regulation of expression of some of
the genes related to mitochondrial function in the Tg
mouse hippocampus in young adult to middle aged pe-
riods, might be an indication of cellular attempts to sus-
tain normal metabolic activity in the face of increased
demand for bioenergetic output. Tomm20, Cds2, Mars2,
and Mtch2 were among the mitochondrial genes identified
as exhibiting distinct patterns of differential expression
across ages in Tg vs. wt mouse hippocampi, especially
between the ages of 4.5 and 14.5 months (Figure 7).
The expression ofTomm20 increased steadily from 10 days
to 14.5 months of age in Tg mice, whereas the pattern of
expression in wt mouse hippocampus exhibited both
peaks and valleys over the same period of maturation. The
expression of Cds2 and Mars2 peaked in Glud1 mouse
hippocampi at 9 months of age and plateaued or moder-
ately decreased after that (Figure 7). The expression of the
same two genes in the wt mouse hippocampus lagged
behind that in the Tg. The importance of Cds2 in mito-
chondrial and brain function was described in a preceding
section. The gene Mars2 codes for a methionyl-tRNA syn-
thetase, a mitochondrial matrix enzyme whose malfunc-
tion causes a neurodegenerative phenotype in flies and a
recessive form of ataxia in humans [86].
The last in this group of mitochondria-related genes
that were differentially expressed in Tg vs. wt mouse
hippocampi was Mtch2 (mitochondrial carrier homolog 2)
which exhibited a different pattern of expression in both
Tg and wt hippocampi than those of Tomm20, Cds2, and
Mars2 but the overall levels of expression of Mtch2 were,
again, higher in Tg than wt mice (Figure 7). The protein
encoded by this gene is an inner mitochondrial membrane
protein presumed to function as a transport carrier and to
cause mitochondrial membrane depolarization and activa-
tion of the cascade of events that lead to mitochondria-
associated apoptosis [87]. Although the function of Mtch2
has been described for liver mitochondria, Mtch2 is also
highly expressed in the mouse hippocampus [88]. Based
on the pro-apoptotic function of Mtch2, the chronically
higher expression of this gene in adult and older Tg mice
compared with wt mice, coupled with the lower expres-
sion level in Tg than wt mouse hippocampi of the anti-
apoptotic gene Birc6 (described above), might enhancethe probability of age-associated neuronal cell losses in
the hippocampus of the Glud1 mice.
PCR Confirmation of patterns of expression of genes in
Tg and wt hippocampus
The expression in mouse brain, and especially in the
hippocampus, of many of the genes described above was
confirmed through reports in the scientific literature and
through searches in the Allen Brain Atlas (http://www.
brain-map.org/). For most of the genes described in this
paper, such confirmation was obtained. In order to
confirm a few of the gene expression patterns that we
observed using the GeneChips, we performed parallel
quantitative PCR analyses of select genes across the age
spectrum. The results of the combined PCR and micro-
array analyses are shown for three such genes in Figure 8.
Although the magnitude of differences between Tg and
wt hippocampi in different age groups detected by PCR
did not exactly match the values obtained by microarray
analyses, the overall patterns of the PCR-measured gene
expression in these limited number of samples appeared
to reproduce those observed by microarray analyses.
Conclusions
A global assessment of the changes in the categories
of Neuronal development, Nerve process extension,
excitability, Synapse formation, Intracellular signaling,
Metabolic regulation, Ion transport, and Protein homeo-
stasis, was obtained in the present study by analyzing
gene expression changes in the hippocampus of Glud1
Tg and wt mice from 10 days of life to the old age of
20 months. To our knowledge, this is the first study to
explore whole genome transcriptomic changes across
the life-span of mice and, specifically, the life-span of
two genotypes of C57BL/6 mice, the Glud1 Tg and wt
mice. We could not find literature references or brain
maps that present the patterns of gene expression in
mouse brain, or mouse hippocampus in particular,
across the ages from10 days to 20 months. A few gene
expression patterns have been traced up to 56 days
of mouse post-natal life by the Allen Brain Atlas
(http://www.brain-map.org/). However, because of the
limited span of ages examined in this brain mapping
effort, these studies do not provide sufficient informa-
tion about changes in gene expression beyond two
months of age.
Among the many changes in gene expression levels
during development, maturation, and aging that are
described in the present study, a few stand out as being
important to neuronal development, function, and sur-
vival in the hippocampus. With regard to the aging
process, and regardless of the genotype of the mice,
there was an age-associated significant decrease in the
expression of genes related to Neurogenesis, Neuronal
Figure 7 Comparison of patterns of expression in Glud1 Tg vs wt mice of four genes related to mitochondrial structure and function.
The genes are Tomm20 (A), Cds2 (B), Mars2 (C), and Mtch2 (D). RMA-normalized expression values, after logarithmic transformation (log2), are
shown on Y-Axis. The lines connecting the points are: solid line, Tg; dotted line, wt.
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an increase in genes related to Neuro-inflammation,
Voltage-gated channel activity, and Regulation of synaptic
transmission. As pointed out in other sections of this
paper and in previous publications [35,89], the up-
regulation of inflammatory response genes appears to be a
common characteristic of aging in the CNS. The up-
regulation of voltage-gated channels, primarily potassium
channels, is a novel observation. Changes in ion channel
expression would be an important component in the con-
trol of neuronal function and viability. Increased neuronal
excitation due to Glu hyperactivity is known to lead to
intracellular and intra-mitochondrial calcium accumula-
tion and, potentially, cell death [2], thus decreases in the
excitability that results from increased expression of
certain potassium channels would protect neurons from
Glu-induced hyper-excitability.
Among the major differences between the Glud1 Tg
and wt mice during development and aging was the dif-
ferential expression of genes related to Protein homeo-
stasis—i.e., genes associated with protein ubiquitinationand proteasomal degradation. As was pointed out in other
sections in this paper, increases in protein ubiquitination,
protein endocytosis, and protein degradation may influ-
ence synapse formation and synaptic function during
development, and the same processes may affect neuronal
excitability and synaptic activity in the CNS during aging.
Increased protein ubiquitination and degradation are also
a characteristic of cellular stress response and the in-
creased expression of genes related to ubiquitin conjuga-
tion during the aging process was previously described for
hippocampus nerve cells [90]. In our studies, we observed
not only up-regulation of genes for ubiquitin conjugation,
but also genes for protein degradation, and, interestingly,
these increases in gene expression during the aging
process were not of the same magnitude in Tg as in wt
mice. These transcriptomic observations indicate a higher
stress level, accelerated aging, and possibly increased
attempts to control synaptic function and excitability in
the Glud1 Tg mice as compared with wt mice.
The regulation of mitochondrial function across age as
determined by gene changes that alter mitochondrial
Figure 8 Comparison of the ratio of Tg/wt expression across age of three significant genes as assessed by GeneChip and qPCR
methods. The genes are Dnm1 (A), Cttn (B), and Sort1 (C). Shown on the Y-axis are the ratios Tg/wt of the logarithmic transformations (log2) of
RMA-normalized expression values.
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solute transport, might be some of the most important
aspects of the aging process revealed by the results of
our studies. Several studies have previously identified
changes in gene expression with advancing age as fitting
within the category of mitochondrial dysfunction and
oxidative stress [69,91,92]. And as has been pointed out
before, altered mitochondrial oxidative phosphorylation
and the generation of reactive oxygen species represent
the type of dysfunction that leads to cell and organ sen-
escence [93]. Of particular interest in our studies were
the differences in genes associated with mitochondrial
protein transport, such as TOMM20 and MTCH2, iron
transport, enzyme regulation, e.g. cytochrome oxidase
subunits, and mitochondrial lipid metabolism. We have
commented already on the significance of the differential
expression of some of these genes in wt vs. Tg mouse
hippocampi. It is worth pointing out again the relevance
in terms of mitochondrial function of the increased ex-
pression of TOMM20 in the Tg mice. TOMM20 is an
important component of the pathway that maintains
normal mitochondrial function and whose loss of func-
tion could contribute to the accumulation of dysfunc-
tional mitochondria [94]. The increased expression of
TOMM 20 in the Glud1 Tg mouse hippocampus during
development and adulthood may be a direct response to
the increased need for GLUD1 protein translocation
from the cytoplasm into the mitochondrial matrix. Yet,
when one considers the increases in Tomm20 expression
in combination with the other differential changes in
mitochondrial gene expression in Glud1 Tg vs. wt mice,
it would appear that these differential expression charac-
teristics reflect adaptive or compensatory changes made
by brain cells to overcome the increased stress exerted
by altered metabolic states in the Glud1 Tg mice.
Methods
Experimental animals
The procedure for generating the Tg mice was described
in detail previously [32]. Age-matched wt mice of the
same genetic background (C57BL/6) were used as the
controls. All animals were housed in a 12 hour light/
dark cycle with food and water ad libitum. All animal
procedures were performed in accordance with guide-
lines established by the University of Kansas IACUC.
Male Glud1 Tg and wt mice at five different ages were
used: 10 day old, 4.5 month, 9 month, 14.5 month, and
20 month old. A total of 3 Tg and 3 wt mice were used
for transcriptomic studies of each age group.
RNA extraction and microarray data generation
The mice used for the transcriptomic studies were anes-
thetized under CO2 anesthesia, the hippocampi dissected
out from the brains, flash frozen in liquid nitrogen, andstored at -80°C prior to total RNA extraction. Total RNA
samples were extracted from the dissected hippocampi
using the Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA,
USA). To prepare targets for subsequent GeneChip
hybridization, One-Cycle cDNA Synthesis Kit from Affy-
metrix (Santa Clara, CA, USA) was used according to the
manufacturer’s instructions. The Affymetrix GeneChip
Mouse Genome 430 2.0 arrays designed to interrogate ex-
pression of over 39,000 mouse gene transcripts, were used
for the hybridization. Subsequent washing and staining
steps were performed on a GeneChip Fluidics 450 Station
and the chips were scanned on a GeneChip Scanner 3000
(Affymetrix). Instrument control and data collection were
carried out using GeneChip Operating Software (GCOS,
ver 1.1.1). In order to minimize experimental variability,
all steps in tissue dissection, RNA isolation and microarray
operation were performed by a single investigator. The
quality and quantity of the original RNA samples and of
the cRNA probes generated for array hybridization were
determined with an Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA, USA), and a NanoDrop ND-
1000 Spectrophotometer (Thermo Scientific, Wilmington,
DE, USA). The microarray data generated from all chips
met the quality control criteria set by Affymetrix, includ-
ing low background and noise, positive detection of QC
probesets such as bioB, percentage of genes called present
in normal range (generally between 40-60%), similar
scaling factors across all chips, and Acceptable 3’/5’
ratios. All microarray data were deposited into the
NCBI GEO (Gene Expression Omnibus) database with
accession number GSE48911.
Transcriptomic data analysis
The GeneChip transcriptomic data collected across the
five age points of Tg and wt mouse hippocampus were
analyzed: a) at each individual age; b) across the develop-
mental stage (the first three age groups); c) across the
aging process (the last three age groups); and d) across
all five age points. For each analysis, the GeneChip CEL
data were first normalized by the Robust Multiarray
Average (RMA) algorithm [95]. Prior to each identifica-
tion of genes showing significant differential expression
patterns between Tg and wt, probesets that were de-
tected to be non-expressed, i.e., those with absence calls
in all analyzed samples, were filtered out and excluded
from further analyses. In addition, probesets that were
designed solely for the purpose of chip quality control
(monitoring hybridization target preparation and array
hybridization), i.e., those with the ID prefix AFFX, were
also filtered out. These filtering steps were employed in
order to reduce the number of comparisons in subse-
quent analyses and thus reduce the FDR.
To identify differentially expressed genes at each
individual age point, SAM (Significance Analysis of
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expression data mining [96], was first used with the
threshold for calling differential gene expression set at
fold change ≥ 1.3 and FDR ≤ 1%. This was followed by
Cyber-T analysis [97] in order to confirm expression pat-
terns of differential genes identified by SAM, using the
criterion of Bayesian P value ≤ 0.05. To identify genes
showing both age-dependent change and differential
expression between Tg and wt, a software package called
EDGE (http://www.genomine.org/edge/) was used [98].
Gene hierarchical clustering was performed using the
software GeneSpring GX (Agilent Technologies). Gene
Ontology (GO) and Biological Pathway analyses were con-
ducted with DAVID (http://david.abcc.ncifcrf.gov/) [99].
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